Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Neurology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16096813
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.

  2005cited by this paper
• Genetic association of low density lipoprotein receptor and Alzheimer's disease.

  2005cited by this paper
• Role of CETP inhibitors in the treatment of dyslipidemia

  2004cited by this paper
• Increasing HDL Cholesterol Levels.

  2004cited by this paper
• Cholesteryl ester transfer protein promoter single‐nucleotide polymorphisms in Sp1‐binding sites affect transcription and are associated with high‐density lipoprotein cholesterol

  2004cited by this paper
• An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease.

  2004cited by this paper
• Cholesterol, statins and dementia

  2004cited by this paper
• Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues

  2004cited by this paper
• Association of 3′-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer’s disease

  2003cited by this paper
• Alzheimer's disease: the cholesterol connection

  2003cited by this paper
• Polymorphisms in the CETP gene and association with CETP mass and HDL levels.

  2003cited by this paper
• Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease.

  2003cited by this paper
• ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease.

  2003cited by this paper
• Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.

  2003cited by this paper
• Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease

  2003cited by this paper
• Unique lipoprotein phenotype and genotype associated with exceptional longevity.

  2003cited by this paper
• The role of cholesterol in pathogenesis of alzheimer’s disease

  2003cited by this paper
• Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.

  2003cited by this paper
• Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease Published, JLR Papers in Press, March 16, 2003. DOI 10.1194/jlr.R200018-JLR200

  2003cited by this paper
• Cholesterol and pathological processes in Alzheimer's disease

  2002cited by this paper
• Apolipoprotein E (ApoE) Isoform-dependent Lipid Release from Astrocytes Prepared from Human ApoE3 and ApoE4 Knock-in Mice*

  2002cited by this paper
• Cholesterol metabolism in the brain

  2001cited by this paper
• Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease.

  2001cited by this paper
• High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils.

  2000cited by this paper
• New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation.

  2000cited by this paper
• Cholesteryl ester transfer protein in human brain

  1992cited by this paper
• Peripheral sensory neuropathy and cisplatin chemotherapy

  1984cited by this paper

• Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease

  2025cites this paper
• Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity

  2024cites this paper
• Dynamic functional network connectivity and its association with lipid metabolism in Alzheimer's disease

  2024cites this paper
• CETP inhibitor evacetrapib enters mouse brain tissue

  2023influential citation
• The Evolving Role of Cholesteryl Ester Transfer Protein Inhibition Beyond Cardiovascular Disease.

  2023cites this paper
• Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia

  2023cites this paper
• Therapeutic effects of crude extracts of Bacopa floribunda on beta-amyloid 1-42-induced Alzheimer’s disease via suppression of dyslipidemia, systemic inflammation and oxidative stress in male Wistar Rats

  2022cites this paper
• Algorithms For Preventive Measures For Disease Prevention And Antioxidant Protection

  2022cites this paper
• The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain

  2022cites this paper
• Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

  2021cites this paper
• Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease

  2021cites this paper
• High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease

  2020cites this paper
• Adipose-Derived Molecules–Untouched Horizons in Alzheimer’s Disease Biology

  2020cites this paper
• Associations of cholesteryl ester transfer protein (CETP) gene variants with pituitary adenoma.

  2020cites this paper
• Chapter 5 Lipids and Lipoproteins in Alzheimer ’ s Disease

  2018cites this paper
• Frequency of Cardiovascular Genetic Risk Factors in a Calabrian Population and Their Effects on Dementia

  2018cites this paper
• Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia.

  2017cites this paper
• Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters

  2017cites this paper
• CETP Genotype Modifies the Effect of Apolipoprotein ε 4 on Memory Decline in Older Adults

  2017influential citation
• Cholesteryl Ester Transfer Protein Intimately Involved in Dyslipidemia-Related Susceptibility to Cognitive Deficits in Type 2 Diabetic Patients

  2016cites this paper
• The potential of cholesteryl ester transfer protein as a therapeutic target

  2016cites this paper
• Cholesteryl ester transfer protein genotype modifies the effect of apolipoprotein ε4 on memory decline in older adults.

  2016cites this paper
• Genetic markers of cholesterol transport and gray matter diffusion: a preliminary study of the CETP I405V polymorphism

  2015cites this paper
• Population-based analysis of cholesteryl ester transfer protein identifies association between I405V and cognitive decline: the Cache County Study.

  2015cites this paper
• Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.

  2015cites this paper
• Epistasis in the risk of human neuropsychiatric disease.

  2015cites this paper
• Lipids and Lipoproteins in Alzheimer’s Disease

  2015cites this paper
• Population-based analysis of CETP identifies association between I 405 V and cognitive decline : The Cache County Study

  2014cites this paper
• Association between the CETP polymorphisms and the risk of Alzheimer's disease, carotid atherosclerosis, longevity, and the efficacy of statin therapy.

  2014cites this paper
• Retinoids as potential targets for Alzheimer's disease.

  2014cites this paper
• Relationships Between CETP Genetic Polymorphisms and Alzheimer's Disease Risk: A Meta-Analysis

  2014cites this paper
• Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase

  2014cites this paper
• Liver X receptors: emerging therapeutic targets for Alzheimer's disease.

  2013cites this paper
• The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-ε4 Carriers

  2013cites this paper
• The CETP I405V polymorphism is associated with an increased risk of Alzheimer’s disease

  2012cites this paper
• Dyslipidemia and Dementia: Current Epidemiology, Genetic Evidence, and Mechanisms Behind the Associations

  2012cites this paper
• Peripheral cholesterol, metabolic disorders and Alzheimer's disease.

  2012cites this paper
• Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons aged 35 years or older.

  2012cites this paper
• An assessment of CETP sequence variation in relation to cognitive decline and dementia risk.

  2011cites this paper
• Cholesteryl ester transfer protein: The controversial relation to atherosclerosis and emerging new biological roles

  2011cites this paper
• CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer’s disease risk in an APOE-dependent manner

  2011cites this paper
• Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia.

  2010cites this paper
• Cholesterol-related genes in Alzheimer's disease.

  2010cites this paper
• Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions

  2009cites this paper
• Epistasis in sporadic Alzheimer's disease.

  2009cites this paper
• Genetic epidemiology in aging research.

  2009cites this paper
• Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease

  2009cites this paper
• Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease.

  2008cites this paper
• CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.

  2008cites this paper
• Does dementia exist? Dispelling the myth.

  2008cites this paper
• Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.

  2008cites this paper
• The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer’s disease

  2007cites this paper
• Genetic factors affecting HDL levels, structure, metabolism and function

  2007cites this paper
• Genetic Determinants of Human Health Span and Life Span: Progress and New Opportunities

  2007cites this paper
• A genetic-epidemiologic study of Alzheimer’s disease

  2006cites this paper
• Sorting out the complexities of reverse cholesterol transport: CETP polymorphisms, HDL, and coronary disease.

  2006cites this paper